Invest in biotech stocks with confidence

Monthly

$35

/mo
billed monthly
$420 per year
An icon graphic of Gouldy the Finch.
Community. Member-only Discord to chat with our founder and other nerds
Margin of Safety dashboard for making informed decisions in real time
An icon graphic of Gouldy the Finch.
Finch Trades transparently shows our founder's real-money investments
An icon graphic of Gouldy the Finch.
Research notes for news flow from companies and competitive landscapes
An icon graphic of Gouldy the Finch.
Price lock. Keep an active subscription and never be exposed to price increases
An icon graphic of Gouldy the Finch.
Monthly and annual subscriptions have identical benefits.

Annual

$26.25

/mo
billed annually
Save 25% per year
An icon graphic of Gouldy the Finch.
Community. Member-only Discord to chat with our founder and other nerds
Margin of Safety dashboard for making informed decisions in real time
An icon graphic of Gouldy the Finch.
Finch Trades transparently shows our founder's real-money investments
An icon graphic of Gouldy the Finch.
Research notes for news flow from companies and competitive landscapes
An icon graphic of Gouldy the Finch.
Price lock. Keep an active subscription and never be exposed to price increases

Monthly

$35

billed monthly
$420 per year
An icon graphic of Gouldy the Finch.
Community. Member-only Discord to chat with our founder and other nerds
Margin of Safety dashboard for making informed decisions in real time
An icon graphic of Gouldy the Finch.
Finch Trades transparently shows our founder's real-money investments
An icon graphic of Gouldy the Finch.
Research notes for news flow from companies and competitive landscapes
An icon graphic of Gouldy the Finch.
Price lock. Keep an active subscription and never be exposed to price increases
An icon graphic of Gouldy the Finch.
Monthly and annual subscriptions have identical benefits.

Annual

$315

billed annually
$315 per year
An icon graphic of Gouldy the Finch.
Community. Member-only Discord to chat with our founder and other nerds
Margin of Safety dashboard for making informed decisions in real time
An icon graphic of Gouldy the Finch.
Finch Trades transparently shows our founder's real-money investments
An icon graphic of Gouldy the Finch.
Research notes for news flow from companies and competitive landscapes
An icon graphic of Gouldy the Finch.
Price lock. Keep an active subscription and never be exposed to price increases

Money talks. Our members do, too.

"Maxx is simply the best analyst I have come across in the biotech space! His write-ups are brilliant, compelling, and easy to understand, even for a beginner in biotech investing like me.

His insights are unparalleled, and he's generous with his time and insights. Solt DB is a no-brainer for those wanting to invest in biotech."

Arch G.
Member since 2024

"Maxx is a champion of objective evaluation and honest transparency. These principles, in addition to his profound understanding of the technical and financial complexities within the biotech landscape, have allowed me to navigate my allocations more confidently and successfully."

Sam M.
Member since 2022

"Finding an authentic investing community in a clout-chasing social media landscape is nearly impossible. I follow Maxx because he is grounded first in the science, layers on the finance and modeling, and actively rejects the distracting bullshit. His work opens up the biotech world to those of us without the years of study and expertise to have an edge alone."

Chris M.
Member since 2023

FAQs

No. If you keep an active membership, then you'll keep the same price whether it's your first year or tenth year.

If you cancel your membership and rejoin later, then you'll pay the then-current rate, which might be higher. As more features are added and our transparent track record lengthens, we intend to increase membership pricing.

*Professional investors or members monetizing our proprietary work (ex: you have a Substack where you write about biotech stocks) may be requested to pay a higher rate.

Solt DB was built to teach scientists about investing and investors about science. Nearly 65% of members have a STEM background and 35% have a graduate degree.

The finch isn't building WallStreetBets for biotech. We take a measured approach that leaves a margin of safety for entry points, objectively acknowledges risks, and appropriately sizes portfolio allocations to optimize risk/reward profiles.

Solt DB was built to teach scientists about investing and investors about science. Our research carefully explains all the nerdy concepts relevant to an investment with simple language, interactive data visualizations, and scientific illustrations.

The finch has used cyclist Tadej Pogačar's aggressive attacks in the Tour de France to introduce Coherus Oncology's clinical posture, tales of the Chimera to explain Bicycle Therapeutics' drug delivery tools, and the history of the Statue of Liberty to explain how technological hype works. Our public articles provide examples of our accessible writing style.

Members who adhere to a sensible investing approach are likely to realize the most benefit, but results will vary from member to member.

Solt DB memberships are intended for investors with a portfolio of at least $10,000. For example, for every $10,000 of Finch Trades principal, the returns would have outperformed all four of our passive investing benchmarks even after subtracting the cost of an annual membership ($315 per year).

No.

Solt DB doesn't use artificial intelligence (AI), large language models (LLM), generative AI, or chatbots for any part of the platform, including research, written content, image or graphic generation, or financial modeling. We do use human expertise, domain competence, and primary sources to think clearly and objectively about biotech investment opportunities. Additionally, we only use images and graphics from human photographers and artists, and proudly credit their work.

No.

We're here to help! Please contact us and we'll respond as soon as reasonably possible.